Skip to content

Pancreatic Cancer Europe is a European multi-stakeholder platform which aims at bringing together experts from all over Europe including academics, physicians, politicians, patient groups, journalists and industry with a common interest and willingness to improve care for patients with pancreatic cancer.

News

Junior Data Manager vacancy

PCE is recruiting a Junior Data Manager to implement and manage the PancreOs database on registries data, using the platform RedCap. PancreOS is a long-term project aiming at establishing a European platform of stakeholders working on the creation of a network of European Registries on pancreatic cancer. The platform will contain clinical and epidemiological information,  ...Read More »Junior Data Manager vacancy

PancreOS Project Report

Pancreatic cancer is the only cancer with mortality on the rise in both sexes and is currently the 4th largest cause of death by cancer in Europe. Pancreatic cancer registries are a prerequisite if advances in pancreatic cancer research are to be made and the commitments of Member States to effective cancer control fulfilled. To  ...Read More »PancreOS Project Report

17 November 2022, “The importance of pancreatic cancer’s early detection” hosted by the European Parliament

On 17 November 2022, 15:30-17:00 (CET), PCE will promote the online event  "The importance of pancreatic cancer’s early detection", hosted by the European Parliament. The initiative, organized in the framework of World Pancreatic Cancer Day (WPCD), will allow organizations, researchers, patients and Members of the European Parliament to discuss the importance of early detection of  ...Read More »17 November 2022, “The importance of pancreatic cancer’s early detection” hosted by the European Parliament

15 November 2022, “The Neglected Heavy Burden: Pancreatic and Gastric Cancers” at the European Parliament

On 15 November 2022, 13:00-15:00 (CET), the European Parliament will host the event "The Neglected Heavy Burden: Pancreatic and Gastric Cancers", promoted by United European Gastroenterology (UEG), Pancreatic Cancer Europe (PCE), and Digestive Cancers Europe (DiCE). The initiative, organized in the framework of World Pancreatic Cancer Day (WPCD), aims to raise awareness about pancreatic and  ...Read More »15 November 2022, “The Neglected Heavy Burden: Pancreatic and Gastric Cancers” at the European Parliament

Antonella Cardone for PCE at the ESMO Congress 2022

Antonella Cardone, Patient Advocacy Expert, represented PCE at the ESMO Congress on 9 September 2022 in Paris. The ESMO Congress is the most important oncology platform in Europe for clinicians, researchers, patient advocates, journalists, and the healthcare industry from all over the world. The 2022 edition presented the very latest advances in the treatment of cancer  ...Read More »Antonella Cardone for PCE at the ESMO Congress 2022

“PancreOS Project Presentation”, recording and speakers’ presentation are online

On 30 June 2022 PCE held a seminar to present PancreOS, a long-term project that aims at implementing a European network of pancreatic cancer registries. The main goal of the project is to provide a comprehensive view of pancreatic cancer patient management in Europe but also to identify the gaps in reporting pancreatic cancer data.…   …Read More »“PancreOS Project Presentation”, recording and speakers’ presentation are online

Pancreatic Cancer Heatmap now online!

Following several months of development, we are happy to unveil the PCE heatmap. Conceived as a powerful tool to compare the pancreatic cancer patients’ situation in each European country, the heatmap provides information on awareness situation, national policy, diagnosis, research… We are always looking for more data and information to enrich the heatmap. Should you want to add some data for your country, please contact directly the Secretariat.

Visit the PCE heatmap ›

Did you know that Pancreatic Cancer has the lowest survival rate of all cancers?

pancreatic cancer europe

Help us to reverse the Trend!

Pancreatic cancer is currently the 4th leading cause of death by cancer in Europe. If no action is taken, it is set to be 2nd by 20203.

Launched in July 2014 a call for action on pancreatic cancer by Members of the European Parliament has been the key driver for the activities of the platform. Since its launch, Pancreatic Cancer Europe has been developping the Pancreatic Cancer Declaration, in order to ensure real change in European policies for pancreatic cancer patients.

Pancreatic cancer is currently the 4th leading cause of death by cancer in Europe. If no action is taken, it is set to be 2nd by 20203.

Patients affected with pancreatic cancer lose 98% of their healthy life expectancy at the point of diagnosis5.

Today, a diagnosis of pancreatic cancer is generally associated with a death sentence and few patients are alive one year after diagnosis, while an earlier diagnosis could help reduce the mortality of the disease. If diagnosed in time, chances of survival increase.

  1. Farthing, M, Roberts, S, Samuel D, Williams D, et al. Survey of digestive health across Europe: Final report. Part 1: The burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe, United European Gastroenterology Journal, December 2014 vol. 2 no. 6 539-543
  2. Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E, et al. European cancer mortality predictions for the year 2013. Annals of Oncol. 2013; 24:792-800
  3. Pancreatic Cancer Action Network. The alarming rise of pancreatic cancer deaths in The United States: Why we need to stem the tide today, 2012. www.pancan.org/wp-content/uploads/2013/01/incidence_report_2012_executive_summary.pdf [Last accessed April 2014]
  4. Carrato et al, 2015. “A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs.” DOI 10.1007/s12029-015-9724-1
  5. Carrato A, Falcone A, Ducreux, M, Valle, J, Parnaby A, Djazouli K, Alnwick-Allu K, Hutchings A, Palaska C, Parthenaki I. A systematic review of the burden of pancreatic cancer in Europe: Real-world impact on survival, quality-of-life, and costs. J Gastrointest Cancer 2015 Sep;46(3):201-11